Sign In

Matt Posard

Builder - Corporate Director, Executive Advisor, Coach, Strategist and Investor

Matt Posard is a seasoned executive with extensive experience in the life sciences, therapeutics, and diagnostics industries. He currently serves as a Member of the Board of Directors at Vizgen, a single-cell spatial genomics instrument company.24

Professional Background

Matt Posard brings over 30 years of general management and commercialization experience to his role at Vizgen.14 His career highlights include:

  • Founding Principal of Explore DNA, a life sciences executive consulting firm, since March 20161
  • Various commercial and general management positions at Illumina, Inc. from 2006 to 2015, including senior executive roles overseeing Global Sales, Marketing, and General Manager of Clinical and Consumer Genomics1
  • President and Chief Commercial Officer of GenePeeks, Inc. from February 2017 to April 20181
  • Chief Commercial Officer of Trovagene, Inc. from March 2015 to April 20161

Board Positions

In addition to his role at Vizgen, Matt Posard holds several other board positions:

  • Chairman at DermTech, Inc.5
  • Executive Chairman at Stemson Therapeutics, LLC5
  • Chairman at Nautilus Subsidiary5
  • Member of the Board of Directors at Deepcell and Vital Bio6

Education

Matt Posard holds a BA degree in Management Science from the University of California, San Diego.13

Expertise

Posard is known for his expertise in:

  • General management
  • Commercialization strategies
  • Life sciences industry
  • Genomics and diagnostics

His extensive experience and industry knowledge make him a valuable asset to Vizgen's Board of Directors, particularly in areas of commercial strategy and market expansion.

Highlights

Mar 9 · linkedin

Thrilled to announce #StemsonTx and #Aderans enter into a strategic licensing pact paving the way to a hair growth revolution for women and men!

Jun 9 · linkedin

Very exciting to see symbiotic excellence — Geneyx Genomex Ltd. and Oxford Nanopore Technologies combining technology strengths to streamline/improve clinical interpretation.

Oxford Nanopore, Geneyx to Develop Software for Clinical Nanopore Sequencing Jun 09, 2023 | staff reporter NEW YORK – Oxford Nanopore Technologies said Friday that it is joining with Israeli software startup Geneyx to develop a technology platform for analysis and clinical reporting of nanopore sequencing data.

Geneyx makes an artificial intelligence-driven genetic data analysis and interpretation platform to improve risk prediction and diagnostic yield.

UK-based Oxford Nanopore said that the new software will be designed to load, visualize, and annotate nanopore sequencing data for "immediate use" for newborn screening and for research and diagnosis of rare diseases. The technology will integrate with the nanopore sequencing company's existing Epi2Me cloud-based analysis platform, which provides secondary sequence analysis.

The firms will launch the partnership with a series of pilot projects to test the software in clinical settings. They did not offer a timetable for a commercial launch.

"Through this seamless integration, customers will benefit from the combined power of nanopore sequencing with Geneyx's AI-powered analysis for an added layer of insight to support critical workflows such as newborn screening and research into rare disease," Oxford Nanopore CEO Gordon Sanghera said in a statement.

"This will enable us to deliver robust and accurate genetic insights to healthcare providers, including a comprehensive genomic solution for long-read whole-genome sequencing analysis," said Geneyx CEO David Yizhar. "Together, we will elevate research and diagnostics, empowering patients and researchers seeking answers."

Geneyx, which is based in Herzliya, Israel, and Foster City, California, raised $6.5 million in a seed funding round in 2021.

Related Questions

What is Explore DNA, and what does it specialize in?
How did Matt Posard's role at Illumina prepare him for his current positions?
What are some of the key achievements of Matt Posard in the life sciences industry?
How has Matt Posard's experience at GenePeeks influenced his work at Vizgen?
What are the main projects Matt Posard is currently involved in at Vizgen?
Matt Posard
Matt Posard, photo 1
Matt Posard, photo 2
Add to my network

Location

San Diego, California, United States